REG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Regency Centers Corp (REG) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and stable growth trends make it a solid choice for long-term investment. While there are some insider selling activities, the overall outlook remains favorable for a patient investor.
The stock's technical indicators show mixed signals. The MACD histogram is negative and expanding, indicating bearish momentum. RSI is neutral at 46.414, suggesting no clear overbought or oversold conditions. However, the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near a key support level (S1: 77.196). This suggests potential for a rebound in the near term.
Strong financial performance in Q4 2025 with revenue up 8.50% YoY, net income up 139.65% YoY, and EPS up 136.96% YoY.
Positive analyst sentiment with multiple price target upgrades and buy ratings.
The company's grocery-anchored portfolio is considered 'best-in-class' by analysts, with strong organic growth and selective external growth opportunities.
Insider selling activity has increased significantly (331.08% over the last month).
The MACD indicator shows bearish momentum, and the stock is down 1.69% in the regular market.
Mizuho downgraded the stock to Neutral, citing premium valuation and slowing growth profile.
In Q4 2025, Regency Centers reported strong financial results: Revenue increased to $404.19M (+8.50% YoY), Net Income rose to $199.07M (+139.65% YoY), and EPS grew to $1.09 (+136.96% YoY). However, Gross Margin slightly declined to 43.72 (-0.09% YoY).
Analysts are generally positive on REG. Recent upgrades and price target increases include Barclays ($85), Truist ($84), BofA ($86), and Morgan Stanley ($85). Analysts highlight healthy earnings growth, below-average financial leverage, and a strong grocery-anchored portfolio. However, Mizuho downgraded the stock to Neutral, citing valuation concerns.
